Pharmacological Characteristics of Lacobacillus gasseri OLL2809 and its Application to the Endometriosis Therapy

In: Journal of Women’s Health, Issues & Care · 2014 · vol. 03(04) · doi:10.4172/2325-9795.1000155 · W2313353147
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Lactobacillus gasseri OLL2809 enhanced NK cell activity, inhibited endometrial tissue growth in mice, and improved dysmenorrhea pain in patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This paper describes “Pharmacological Characteristics” of the probiotic Lactobacillus gasseri OLL2809 and its application to endometriosis therapy, but the provided text contains only publisher and journal-format information rather than study design, participant/population details, experimental methods, or results. No key pharmacological findings, outcome measures, or limitations are explicitly stated in the excerpt. Because the actual scientific content is not included, it is not possible to extract the main conclusions or any explicit caveats from what is shown. This paper is centrally about endometriosis — it is presented as applying Lactobacillus gasseri OLL2809 to endometriosis therapy.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Many probiotics have been developed for the treatment of diseases. However, there is no probiotics for the treatment of endometriosis. In the pathology of endometriosis involvement of impaired peritoneal immunosurveillance systems has been well established, suggesting the impaired activity of natural killer (NK) cell in the peritoneal cavity. Therefore, Lacobacillus gasseri OLL2809 (L. gasseri OLL2809) was selected from human as a probiotic Lactobacillus to exhibit a strong stimulatory activity for IL-12 (p70) production followed by the activation of NK cell. In a mice endometriosis model, OLL2809 significantly inhibited the growth of the endometrial tissue. In a rat implanted endometriosis model, the healing of the endometriosis was significantly enhanced by the treatment with L. gasseri OLL2809. In clinical study enrolled by patients with endometriosis, L. gasseri OLL2809 showed significant efficacy on the pain intensity at the menstrual period and significant improvement on the verbal rating scale of dysmenorrhea, although serum level of CA-125 was not affected by the ingestion of L. gasseri OLL2809. No clinical adverse effect was observed by the treatment with L. gasseri OLL2809. These findings show that OLL2809 is useful and safety probiotic to improve quality of life (QOL) in the endometrial patients.
Full text 8,163 characters · extracted from oa-doi-fallback · click to expand
SciTechnol is an online publisher that enjoys global presence with International Journals on Clinical, Medical, Environmental, Pharmaceutical, Neurosciences, Technological and Business Management. SciTechnol offers a meaningful platform to the global scientific community to discuss and share knowledge while disseminating research findings globally.The mission of SciTechnol is to publish, promote and disseminate the work of medical researchers in a manner that exemplifies the highest standards in research integrity.SciTechnol offers a prompt and efficient review process that enhances the quality of the publication. The ultimate goal of SciTechnol is to aid the scientific community with periodicals focusing on SciTechnol is an innovative platform that encourages multidisciplinary, peer reviewed international journals committed to promote research in the fields of science and technology. It encourages scientific research by disseminating the researched outcome in vast areas of pure and applied sciences by offering a hybrid publication model that allows the researchers to publish through open access as well as subscription modes. This flexibility encourages a cross section of researchers and scientific fraternity to widely publish their recent innovations as research articles, review articles, commentaries, conference proceedings, book reviews and letters to the editor. We follow a standard double peer reviewed process and operate through Editorial Manager system that facilitates efficient online article submission, review and publication. Journal of Addictive Behaviors, Therapy & Rehabilitation is a peer-reviewed scholarly journal in the field of addiction science that aims to publish the most complete and reliable source of information on the discoveries and current developments in the mode of research articles, review articles, case reports, short communications, etc. in all areas of addiction science and making them accessible online freely without any restrictions or any other subscriptions to researchers worldwide. Journal of Addictive Behaviors, Therapy & Rehabilitation focuses on the topics include, but are not restricted to: Drug rehabilitation, Drug Abuse, Criminal justice and Counseling, Cognitive Behavior Therapy, Chronic and acute intoxication, Opioid Toxicity and Overdosage, Cognitive therapies of addiction recovery, Internet Addiction, Alcoholism, Smoking, Work addiction, Mobile addiction, Food addiction, Gambling, Shopping addiction, Sex addiction. The journal is using Editorial Tracking System for quality in peer-review process. Editorial Tracking is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Addictive Behaviors, Therapy & Rehabilitation or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process. Journal of Aging and Geriatric Medicine (AGM) is a peer reviewed Open Access journal that publishes research information in the field of Geriatric Medicine and Geriatrics with a view to disseminate recent advancements for improvement of health care systems of elderly or older population across the globe. The Journal provides a platform for clinicians, surgeons, researchers and health professionals to contribute their findings and awareness among community and aims to set a forum for publication, education, and exchange of opinions in various aspects of Aging research and clinical Geriatrics in all medical and surgical subspecialties. The Journal focuses on the wide spread dissemination of recent advances in all research areas of Geriatric Medicine that includes: Gerontology, Aging Science, Biology of Aging, mechanisms of aging, Aging & Disability, Aging Associated Diseases (Parkinson, Alzheimer), Aging Demographics, Geriatric Psychiatry, Geriatric Diseases and Syndromes, Diagnostics, Treatment and Clinical Interventions in Aging. Submission and processing of the manuscripts can be done online through the Editorial Manager System which helps maintaining the quality of the peer review process and provides easy access to the authors to track the status of the manuscript, including evaluation and publication in an automated way. Subject experts under the supervision of the Editor-in-Chief review the manuscripts. Approval of at least two independent reviewers and the editor is mandatory for the acceptance of the manuscript for publication. Journal of Aging and Geriatric Medicine (AGM) is a peer reviewed Open Access journal that publishes research information in the field of Geriatric Medicine and Geriatrics with a view to disseminate recent advancements for improvement of health care systems of elderly or older population across the globe. The Journal provides a platform for clinicians, surgeons, researchers and health professionals to contribute their findings and awareness among community and aims to set a forum for publication, education, and exchange of opinions in various aspects of Aging research and clinical Geriatrics in all medical and surgical subspecialties. The Journal focuses on the wide spread dissemination of recent advances in all research areas of Geriatric Medicine that includes: Gerontology, Aging Science, Biology of Aging, mechanisms of aging, Aging & Disability, Aging Associated Diseases (Parkinson, Alzheimer), Aging Demographics, Geriatric Psychiatry, Geriatric Diseases and Syndromes, Diagnostics, Treatment and Clinical Interventions in Aging. Submission and processing of the manuscripts can be done online through the Editorial Manager System which helps maintaining the quality of the peer review process and provides easy access to the authors to track the status of the manuscript, including evaluation and publication in an automated way. Subject experts under the supervision of the Editor-in-Chief review the manuscripts. Approval of at least two independent reviewers and the editor is mandatory for the acceptance of the manuscript for publication. The Journal is following double blind peer-review for quality in review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members of Journal of Applied Bioinformatics & Computational Biology or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the online tracking system. Manuscripts can be submitted via Online Submission or send us an e-mail attachment to the Editorial Office at [email protected] 2016 Journal Impact Factor is the ratio of the number of citations achieved in the year 2016 based on Google Search and Google Scholar Citations to the total number of articles published in the last two years i.e. in 2014 and 2015. Impact factor measures the quality of the Journal. Algorithms are a set of unambiguous instructions that, given some set of initial conditions, can be performed in a prescribed sequence to achieve a particular goal. Programming is the set of instructions given to perform a task. Journals Related to Algorithms and Programming Research and Reports on Mathematics, Journal of Biochemical Engineering & Bioprocess Technology, Journal of Bioengineering and Medical Technology Homology modeling, otherwise called comparative modeling of protein, alludes to developing a nuclear determination model of the "objective" protein from its amino corrosive succession. In Homology Modeling, we test three-dimensional structure of a related homologous protein (the "layout"). Journal of Computer Engineering & Information Technology, Journal of Molecular Biology and Methods, Advanced Biomedical Research & Innovation, Journal of Bioengineering and Medical Technology

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisdysmenorrhea

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (42)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK